Weiner Joshua, Duran-Struuck Raimon, Zitsman Jonah, Buhler Leo, Sondermeijer Hugo, McMurchy Alicia N, Levings Megan K, Sykes Megan, Griesemer Adam
Columbia Center for Translational Immunology, Columbia University Medical Center, 650 West 168 Street, Black Building 15 Floor, New York, NY 10032,
Department of Surgery, University Hospital of Geneva, 24 Rue Micheli du Crest, Geneva 141211, Switzerland,
Transplant Direct. 2015 Feb 1;1(1):1-7. doi: 10.1097/TXD.0000000000000511.
Regulatory T cells (Treg) are being explored for their tolerance-inducing capabilities. Freezing and banking Treg for future use makes this strategy more clinically applicable. We aimed to devise an improved method of expanding and cryopreserving Treg to maximize yield, purity, and function for use in xenotransplantation.
Baboon peripheral blood mononuclear cells (PBMC) were isolated from whole blood. CD4+/CD25 cells were isolated by flow cytometric sorting and expanded for 26 days in culture with IL-2, anti-CD3 antibody, artificial APCs transfected with human CD58, CD32, and CD80, and rapamycin with weekly restimulations. Expanded Treg were frozen for 2 months then thawed and cultured for 48 hours in medium plus 1) no additives, 2) IL-2, 3) anti-CD3 antibody, 4) IL-2 + anti-CD3 antibody, and 5) IL-2 + anti-CD3 antibody + L cells. Phenotype and suppression were assessed after expansion, immediately after thawing, and after culturing.
We expanded purified baboon Treg more than 10,000-fold. Expanded Treg exhibited excellent suppression in functional assays. Cryopreservation decreased suppressive function without changing phenotype, but increasing amounts of reactivation after thawing produced significantly better viability and suppressive function with a trend towards greater Treg purity.
We produced numbers of expanded Tregs consistent with clinical use. In contrast to some previous reports, both Treg phenotype and suppressive function were preserved or even enhanced by increasing amounts of restimulation after thawing. Thus, banking of expanded recipient Tregs for infusion should be possible.
调节性T细胞(Treg)因其诱导免疫耐受的能力而受到研究。冷冻保存Treg以备将来使用使该策略更具临床适用性。我们旨在设计一种改进的方法来扩增和冷冻保存Treg,以最大化其产量、纯度和功能,用于异种移植。
从狒狒全血中分离外周血单个核细胞(PBMC)。通过流式细胞术分选CD4+/CD25细胞,并在含有白细胞介素-2(IL-2)、抗CD3抗体、转染了人CD58、CD32和CD80的人工抗原呈递细胞(APC)以及雷帕霉素的培养基中培养26天,每周进行再刺激。将扩增后的Treg冷冻2个月,然后解冻,并在培养基中培养48小时,培养基添加以下成分:1)无添加剂;2)IL-2;3)抗CD3抗体;4)IL-2 +抗CD3抗体;5)IL-2 +抗CD3抗体 + L细胞。在扩增后、解冻后立即以及培养后评估细胞表型和抑制功能。
我们将纯化的狒狒Treg扩增了超过10000倍。扩增后的Treg在功能试验中表现出优异的抑制能力。冷冻保存降低了抑制功能,但未改变细胞表型,不过解冻后增加再刺激量可显著提高细胞活力和抑制功能,且Treg纯度有增加趋势。
我们获得的扩增Treg数量符合临床应用要求。与之前的一些报道不同,解冻后增加再刺激量可保留甚至增强Treg的表型和抑制功能。因此,扩增后的受体Treg冻存后用于输注应该是可行的。